Phase-II trial of idarubicin, fludarabine, cytosine arabinoside, and filgrastim (Ida-FLAG) for treatment of refractory, relapsed, and secondary AML

H. Tilman Steinmetz, Armin Schulz, Peter Staib, C. Scheid, Axel Glasmacher, Achim Neufang, Jeremy Franklin, Hans Tesch, Volker Diehl, P. Dias Wickramanayake

Annals of Hematology · 1999 · 64 citations · 37 references

Concepts

References

37